Treating Coronavirus Symptoms With Ibuprofen Is Probably Okay, Doctors Say

The clarification follows doubt about whether ibuprofen could worsen symptoms of COVID-19.

Richard B. Levine/Levine Roberts/Newscom/Zuma

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to Mother Jones' newsletters.

Despite early warnings from France’s health minister and the World Health Organization, ibuprofen is still considered a safe treatment for symptoms of COVID-19, the disease caused by the coronavirus, such as fever and headache.

In a tweet on Saturday, French health minister Olivier Véran advised against the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen for treating COVID-19, suggesting that they could aggravate symptoms. The warning could stem from a recent study published in The Lancet Respiratory Medicine suggesting that anti-inflammatory medication could increase an individual’s susceptibility to infection, according to NPR.

After initially endorsing this recommendation and advising the use of acetaminophen instead, the WHO has reversed course, assuring the public that there is no clinical evidence to suggest that ibuprofen, sold under brand names including Motrin and Advil, worsens the symptoms of COVID-19.

As Dr. Angela Rogers, the chair of the intensive care unit’s COVID-19 task force at Stanford University Medical Center, tells NPR, acetaminophen, sold under the brand name Tylenol, is recommended for patients who are sick enough to go to the hospital because it is less likely to damage the kidneys than ibuprofen when taken long-term. But at high doses, acetaminophen can cause damage to the liver.

For now, doctors are indicating that any fever-reducer is an acceptable first-line treatment to symptoms of COVID-19.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.